RESUMEN
BACKGROUND: Acute mesenteric ischemia (AMI) is an emergent vascular disease caused by cessation of the blood supply to the small intestine. Despite advances in the diagnosis, intervention, and surgical procedures, AMI remains a life-threatening condition. Prostaglandin E2 major urinary metabolite (PGE-MUM), the urinary metabolite of prostaglandin E2, is known to be stable in urine and has been suggested to be a valuable biomarker for intestinal mucosal inflammation, such as ulcerative colitis. We therefore investigated whether or not PGE-MUM levels reflect the degree of ischemia in an intestinal ischemia-reperfusion model. METHODS: Male rats were used to establish a superior mesenteric artery occlusion (SMAO) group, in which the superior mesenteric artery was clamped, and a sham group. The clamping times in the SMAO group were either 30 minutes or 60 minutes, and reperfusion times were either 3 hours or 6 hours, after which PGE-MUM values were measured. RESULTS: The histological injury score of the SMAO (30-minute ischemia and 6-hour reperfusion group, 1.8 ± 0.4; 60-minute ischemia and 6-hour reperfusion group, 4.7 ± 0.5) and were significantly greater than that of the sham group (0.4 ± 0.7, p < 0.05). The PGE-MUM levels in the SMAO group (30-minutes ischemia and 6-hour reperfusion group, 483 ± 256; 60-minutes ischemia and 6-hour reperfusion group, 889 ± 402 ng/mL) were significantly higher than in the sham group (30-minute and 6-hour observation group, 51 ± 20; 60-minute and 6-hour observation group, 73 ± 32 ng/mL; p < 0.05). Furthermore, the PGE-MUM value was corrected by the concentration of urinary creatinine (Cr). The PGE-MUM/urinary Cr levels in the SMAO group were also significantly higher than in the sham group ( p < 0.05). CONCLUSION: We found that intestinal ischemia-reperfusion increased urinary PGE-MUM levels depending on the ischemic time. This suggests the potential utility of PGE-MUM as a noninvasive marker of intestinal ischemia.
Asunto(s)
Biomarcadores , Modelos Animales de Enfermedad , Isquemia Mesentérica , Daño por Reperfusión , Animales , Masculino , Ratas , Biomarcadores/orina , Daño por Reperfusión/orina , Daño por Reperfusión/diagnóstico , Daño por Reperfusión/metabolismo , Isquemia Mesentérica/orina , Isquemia Mesentérica/diagnóstico , Ratas Sprague-Dawley , Dinoprostona/orina , Isquemia/orina , Isquemia/diagnóstico , Enfermedad AgudaRESUMEN
Recognizing patients at early phases of chronic kidney disease (CKD) is difficult, and it is even more challenging to predict acute kidney injury (AKI) and its transition to CKD. The gold standard to timely identify renal fibrosis is the kidney biopsy, an invasive procedure not usually performed for this purpose in clinical practice. SerpinA3 was identified by high-resolution-mass-spectrometry in urines from animals with CKD. An early and progressive elevation of urinary SerpinA3 (uSerpinA3) was observed during the AKI to CKD transition together with SerpinA3 relocation from the cytoplasm to the apical tubular membrane in the rat kidney. uSerpinA3/alpha-1-antichymotrypsin was significantly increased in patients with CKD secondary to focal and segmental glomerulosclerosis (FSGS), ANCA associated vasculitis (AAV) and proliferative class III and IV lupus nephritis (LN). uSerpinA3 levels were independently and positively associated with renal fibrosis. In patients with class V LN, uSerpinA3 levels were not different from healthy volunteers. uSerpinA3 was not found in patients with systemic inflammatory diseases without renal dysfunction. Our observations suggest that uSerpinA3 can detect renal fibrosis and inflammation, with a particular potential for the early detection of AKI to CKD transition and for the differentiation among lupus nephritis classes III/IV and V.
Asunto(s)
Lesión Renal Aguda/orina , Insuficiencia Renal Crónica/orina , Serpinas/orina , alfa 1-Antiquimotripsina/orina , Adulto , Secuencia de Aminoácidos , Animales , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/orina , Biomarcadores/orina , Progresión de la Enfermedad , Diagnóstico Precoz , Femenino , Glomeruloesclerosis Focal y Segmentaria/orina , Humanos , Inflamación/orina , Isquemia/orina , Riñón/irrigación sanguínea , Nefritis Lúpica/clasificación , Nefritis Lúpica/orina , Masculino , Espectrometría de Masas , Persona de Mediana Edad , Pancreatitis/orina , Transporte de Proteínas , Distribución Aleatoria , Ratas , Ratas Wistar , Insuficiencia Renal Crónica/diagnóstico , Adulto Joven , alfa 1-Antitripsina/orinaRESUMEN
OBJECTIVE: To investigate lower urinary tract symptoms (LUTS) and urinary levels of neuroinflammatory, inflammatory, and oxidative stress markers in elderly men with chronic pelvic ischemia (CPI) caused by significant aortoiliac disease. MATERIALS AND METHODS: Thirteen men aged over 60 years, with aorta, unilateral or bilateral common/internal iliac artery occlusion documented by computed tomography angiography or angiography, were enrolled from the vascular surgery department. Twelve sex- and age-matched controls without significant aortoiliac disease were used for comparison. Exclusion criteria included neurogenic bladder dysfunction, bladder or prostate cancer, prostatic surgery, pelvic radiotherapy, or chronic treatment for LUTS. Participants underwent urological examination, including assessment of International Prostate Symptom Score (IPSS), uroflowmetry, postvoid residual (PVR), and prostate volume. Urine samples were collected, and levels of neuroinflammatory (nerve growth factor, NGF), inflammatory (cytokines), and oxidative stress markers (8-hydroxy-2'-deoxyguanosine) were determined by enzyme-linked immunosorbent assay. RESULTS: Groups were similar for age, PVR, prostate volume, and most cardiovascular risk factors. IPSS was higher in patients with CPI (11 ± 3 vs 8 ± 2, Pâ¯=â¯.02), with a significant mean difference between groups of three points. Urinary NGF was significantly higher in men with CPI (3.7 ± 0.8 vs 2.9 ± 0.7, Pâ¯=â¯.02), but no differences were found in inflammatory and oxidative biomarkers among groups. CONCLUSION: Severe CPI in elderly men is associated with a significant increase in LUTS and bladder neurogenic inflammation, as suggested by the increase of NGF release in urine, sensitizing bladder afferents. These findings confirm the relevance of ischemia in bladder function and appear to validate animal models of bilateral iliac artery occlusion.
Asunto(s)
Enfermedades de la Aorta/complicaciones , Enfermedades de la Aorta/orina , Arteriopatías Oclusivas/complicaciones , Arteriopatías Oclusivas/orina , Citocinas/orina , Arteria Ilíaca , Isquemia/etiología , Isquemia/orina , Síntomas del Sistema Urinario Inferior/etiología , Síntomas del Sistema Urinario Inferior/orina , Factor de Crecimiento Nervioso/orina , Anciano , Biomarcadores/orina , Estudios de Casos y Controles , Enfermedad Crónica , Humanos , Masculino , Estrés OxidativoRESUMEN
Nicotinamide adenine dinucleotide (NAD+) extends longevity in experimental organisms, raising interest in its impact on human health. De novo NAD+ biosynthesis from tryptophan is evolutionarily conserved yet considered supplanted among higher species by biosynthesis from nicotinamide (NAM). Here we show that a bottleneck enzyme in de novo biosynthesis, quinolinate phosphoribosyltransferase (QPRT), defends renal NAD+ and mediates resistance to acute kidney injury (AKI). Following murine AKI, renal NAD+ fell, quinolinate rose, and QPRT declined. QPRT+/- mice exhibited higher quinolinate, lower NAD+, and higher AKI susceptibility. Metabolomics suggested an elevated urinary quinolinate/tryptophan ratio (uQ/T) as an indicator of reduced QPRT. Elevated uQ/T predicted AKI and other adverse outcomes in critically ill patients. A phase 1 placebo-controlled study of oral NAM demonstrated a dose-related increase in circulating NAD+ metabolites. NAM was well tolerated and was associated with less AKI. Therefore, impaired NAD+ biosynthesis may be a feature of high-risk hospitalizations for which NAD+ augmentation could be beneficial.
Asunto(s)
Lesión Renal Aguda/metabolismo , Vías Biosintéticas , NAD/biosíntesis , Lesión Renal Aguda/tratamiento farmacológico , Lesión Renal Aguda/orina , Anciano , Animales , Procedimientos Quirúrgicos Cardíacos , Humanos , Isquemia/orina , Ratones , Persona de Mediana Edad , Niacinamida/administración & dosificación , Niacinamida/uso terapéutico , Pentosiltransferasa/metabolismo , Proyectos Piloto , Ácido Quinolínico/metabolismo , Ácido Quinolínico/orina , Resultado del Tratamiento , Triptófano/orinaRESUMEN
BACKGROUND: Cystatin C, a marker of kidney injury, is freely filtered in the glomeruli and reabsorbed by the proximal tubules. Megalin and cubilin are endocytic receptors essential for reabsorption of most filtered proteins. This study examines the role of these receptors for the uptake and excretion of cystatin C and explores the effect of renal ischemia/reperfusion injury on renal cystatin C uptake and excretion in a rat model. METHODS: Binding of cystatin C to megalin and cubilin was analyzed by surface plasmon resonance analysis. ELISA and/or immunoblotting and immunohistochemistry were used to study the urinary excretion and tubular uptake of endogenous cystatin C in mice. Furthermore, renal uptake and urinary excretion of cystatin C was investigated in rats exposed to ischemia/reperfusion injury. RESULTS: A high affinity binding of cystatin C to megalin and cubilin was identified. Megalin deficient mice revealed an increased urinary excretion of cystatin C associated with defective uptake by endocytosis. In rats exposed to ischemia/reperfusion injury urinary cystatin C excretion was increased and associated with a focal decrease in proximal tubule endocytosis with no apparent change in megalin expression. CONCLUSIONS: Megalin is essential for the normal tubular recovery of endogenous cystatin C. The increase in urinary cystatin C excretion after ischemia/reperfusion injury is associated with decreased tubular uptake but not with reduced megalin expression.
Asunto(s)
Cistatina C/orina , Isquemia/orina , Riñón/irrigación sanguínea , Proteína 2 Relacionada con Receptor de Lipoproteína de Baja Densidad/fisiología , Animales , Masculino , Ratones , Ratones Transgénicos , Unión Proteica , Ratas , Ratas WistarRESUMEN
Recognition of early stage of diabetic kidney disease, under common practice using biomarkers, namely microalbuminuria, serum creatinine level above 1 mg/dL and accepted definition of diabetic kidney disease associated with creatinine clearance value below 60 mL/min/1.73 m2, is unlikely. This would lead to delay treatment associated with therapeutic resistance to vasodilator due to a defective vascular homoeostasis. Other alternative biomarkers related to the state of microalbuminuria is not sensitive to screen for early diabetic kidney disease (stages I, II). In this regard, a better diagnostic markers to serve for this purpose are creatinine clearance, fractional excretion of magnesium (FE Mg), cystatin C. Recently, renal microvascular disease and renal ischemia have been demonstrated to correlate indirectly with the development of diabetic kidney disease and its function. Among these are angiogenic and anti-angiogenic factors, namely VEGF, VEGF receptors, angiopoietins and endostatin. With respect to therapeutic prevention, implementation of treatment at early stage of diabetic and nondiabetic kidney disease is able to restore renal perfusion and function.
Asunto(s)
Diabetes Mellitus Tipo 2/sangre , Nefropatías Diabéticas/sangre , Isquemia/sangre , Riñón/irrigación sanguínea , Microvasos/patología , Albuminuria/orina , Biomarcadores/sangre , Biomarcadores/orina , Creatinina/sangre , Creatinina/orina , Cistatina C/análisis , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/orina , Nefropatías Diabéticas/orina , Progresión de la Enfermedad , Endostatinas/sangre , Tasa de Filtración Glomerular , Humanos , Isquemia/orina , Riñón/fisiopatología , Magnesio/metabolismo , Magnesio/orina , Eliminación RenalRESUMEN
PURPOSE: To investigate biomarkers of acute renal injury in Wistar rats, subjected to left renal ischemia for 10 minutes, and then compare reperfusion at 24 hours, and at 5, 7, 14 and 21 days after the procedure. METHODS: Eight female and male rats between 60 and 81 days old were used in the Central Animal Facility of the UFMS. Assessed biomarkers included urine protein, urea, creatinine, glucose, sodium, potassium, urine alkaline phosphatase and gamma-glutamyl transferase activities, and protein-to-creatinine ratio; and in serum: urea, creatinine, sodium and potassium, fractional excretion of sodium, potassium, urine flow and creatinine clearance. RESULTS: Greater variance was observed in the parameters at 24 hours and at five days (p<0.05) after reperfusion. On the 21st day, these parameters approximated those obtained for the control group. CONCLUSIONS: Renal ischemia for 10 minutes was sufficient to raise urine levels of protein, glucose, fractional excretion of potassium, urea, creatinine clearance, urine activity of gamma-glutamyltransferase and alkaline phosphatase enzymes in the first 24 hours, up to five days after reperfusion, which may indicate risk of acute kidney injury, according to the RIFLE classification.
Asunto(s)
Lesión Renal Aguda/orina , Biomarcadores/orina , Isquemia/orina , Riñón/irrigación sanguínea , Daño por Reperfusión/orina , Lesión Renal Aguda/sangre , Fosfatasa Alcalina/orina , Animales , Biomarcadores/sangre , Creatinina/sangre , Creatinina/orina , Femenino , Glucosuria , Isquemia/sangre , Masculino , Potasio/sangre , Potasio/orina , Ratas Wistar , Valores de Referencia , Daño por Reperfusión/sangre , Factores de Riesgo , Factores Sexuales , Sodio/sangre , Sodio/orina , Factores de Tiempo , Urea/sangre , Urea/orina , gamma-Glutamiltransferasa/orinaRESUMEN
PURPOSE: To investigate biomarkers of acute renal injury in Wistar rats, subjected to left renal ischemia for 10 minutes, and then compare reperfusion at 24 hours, and at 5, 7, 14 and 21 days after the procedure. METHODS: Eight female and male rats between 60 and 81 days old were used in the Central Animal Facility of the UFMS. Assessed biomarkers included urine protein, urea, creatinine, glucose, sodium, potassium, urine alkaline phosphatase and gamma-glutamyl transferase activities, and protein-to-creatinine ratio; and in serum: urea, creatinine, sodium and potassium, fractional excretion of sodium, potassium, urine flow and creatinine clearance. RESULTS: Greater variance was observed in the parameters at 24 hours and at five days (p<0.05) after reperfusion. On the 21st day, these parameters approximated those obtained for the control group. CONCLUSIONS: Renal ischemia for 10 minutes was sufficient to raise urine levels of protein, glucose, fractional excretion of potassium, urea, creatinine clearance, urine activity of gamma-glutamyltransferase and alkaline phosphatase enzymes in the first 24 hours, up to five days after reperfusion, which may indicate risk of acute kidney injury, according to the RIFLE classification. .
Asunto(s)
Animales , Femenino , Masculino , Lesión Renal Aguda/orina , Biomarcadores/orina , Isquemia/orina , Riñón/irrigación sanguínea , Daño por Reperfusión/orina , Lesión Renal Aguda/sangre , Fosfatasa Alcalina/orina , Biomarcadores/sangre , Creatinina/sangre , Creatinina/orina , Glucosuria , Isquemia/sangre , Potasio/sangre , Potasio/orina , Ratas Wistar , Valores de Referencia , Factores de Riesgo , Daño por Reperfusión/sangre , Factores Sexuales , Sodio/sangre , Sodio/orina , Factores de Tiempo , Urea/sangre , Urea/orina , gamma-Glutamiltransferasa/orinaRESUMEN
BACKGROUND: Acute tubular necrosis (ATN) describes a form of intrinsic acute kidney injury (AKI) that results from persistent hypoperfusion and subsequent activation of the immune system. A glycosylated transmembrane protein, CD147/basigin, is involved in the pathogenesis of renal ischemia and fibrosis. The present study investigated whether CD147 can reflect pathological features and renal dysfunction in patients with AKI. METHODS: Plasma and spot urine samples were collected from 24 patients (12 controls and 12 with ATN) who underwent renal biopsy between 2008 and 2012. In another study, patients undergoing open surgery to treat abdominal aortic aneurysms (AAAs) were enrolled in 2004. We collected urine and plasma samples from seven patients with AKI and 33 patients without AKI, respectively. In these experiments, plasma and urinary CD147, and urinary L-fatty acid-binding protein (L-FABP) levels were measured, and the former expression in kidneys was examined by immunostaining. RESULTS: In biopsy tissues of ATN with severe histological features, CD147 induction was strikingly present in inflammatory cells such as macrophages and lymphocytes in the injured interstitium, but not in damaged tubules representing atrophy. Both plasma and urinary CD147 levels were strikingly increased in ATN patients; both values showed greater correlations with renal dysfunction compared to urinary L-FABP. In patients who had undergone open AAA surgery, urinary and plasma CD147 values in AKI patients were significantly higher than in non-AKI patients at post-operative day 1, similar to the profile of urinary L-FABP. CONCLUSION: CD147 was prominent in its ability to detect AKI and may allow the start of preemptive medication.
Asunto(s)
Lesión Renal Aguda/sangre , Basigina/sangre , Lesión Renal Aguda/orina , Adolescente , Adulto , Anciano , Basigina/orina , Biomarcadores/sangre , Biomarcadores/orina , Estudios de Casos y Controles , Creatinina/sangre , Proteínas de Unión a Ácidos Grasos/sangre , Femenino , Humanos , Isquemia/sangre , Isquemia/orina , Riñón/irrigación sanguínea , Riñón/metabolismo , Riñón/patología , Masculino , Persona de Mediana Edad , Necrosis/sangre , Necrosis/orina , Adulto JovenRESUMEN
Oxidative stress is a leading cause of neuronal damage in ischemic stroke. Melatonin may play a role in the antioxidant response. Melatonin and its metabolites may be involved in the modulation of oxidative stress in human acute stroke. No data are available in humans to establish this relationship. In this context, on the first and the fifth days post-stroke, we assessed serum total antioxidant capacity (TAC) and urine levels of melatonin, 6-sulfatoxymelatonin (aMT6S), and N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), the last compound being produced in the brain after reaction of melatonin with reactive oxygen species. Compared to controls' values, TAC and levels of melatonin and aMT6S were reduced, without difference between the first and the fifth days post-stroke, whereas AFMK levels remained in the normal range at both time points. Melatonin catabolism might be speeded up in acute ischemic stroke in order to increase the antioxidant response.
Asunto(s)
Isquemia/epidemiología , Isquemia/orina , Melatonina/orina , Especies Reactivas de Oxígeno/orina , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/orina , Anciano , Comorbilidad , Femenino , Francia/epidemiología , Humanos , Masculino , Metabolismo , Persona de Mediana Edad , Estrés Oxidativo , Prevalencia , Factores de RiesgoRESUMEN
PURPOSE: Nephron sparing surgery is considered the treatment of choice in most patients with confined renal cancer. Interrupting renal blood flow is often necessary during such surgery, which can induce significant renal injury. We explored the possibility of using urinary NGAL and KIM-1 excretion as novel biomarkers to assess the extent of acute kidney injury after nephron sparing surgery. MATERIALS AND METHODS: The study group included 27 patients who underwent open nephron sparing surgery for enhancing solid renal tumors. During surgery the renal artery was clamped for between 6 and 47 minutes. Urine samples were collected before surgery, and 1, 3, 8, 24, 48 and 72 hours after renal pedicle clamp removal. Urinary levels of NGAL and KIM-1 were determined. RESULTS: Renal artery clamping induced renal injury, as reflected by increased urinary NGAL and KIM-1 in all participants. These increases in urinary NGAL excretion were evident after 1 hour of renal ischemia and lasted for 72 hours. Urinary NGAL correlated with the serum creatinine increase and ischemia duration. Compared with patients without significantly increased serum creatinine, those with significantly increased serum creatinine after nephron sparing surgery had a greater increase in urinary NGAL but not in KIM-1. CONCLUSIONS: Renal injury severity after nephron sparing surgery could be quantitatively assessed by measuring urinary NGAL and KIM-1.
Asunto(s)
Lesión Renal Aguda/etiología , Lesión Renal Aguda/orina , Proteínas de Fase Aguda/orina , Isquemia/orina , Riñón/irrigación sanguínea , Lipocalinas/orina , Glicoproteínas de Membrana/orina , Nefrectomía/efectos adversos , Proteínas Proto-Oncogénicas/orina , Biomarcadores/orina , Receptor Celular 1 del Virus de la Hepatitis A , Humanos , Lipocalina 2 , Nefrectomía/métodos , Nefronas , Receptores ViralesRESUMEN
Evaluation of thrombogenicity is a critical component in the preclinical testing and development of blood pumps. Left ventricular assist devices (LVADs), because of their device routing, can produce thromboembolic showers to the kidney resulting in renal cortical ischemia or infarctions. Although postmortem evaluation of renal pathology can confirm ischemic events and infarctions, there are no validated and highly sensitive real-time measures of renal ischemia in the preclinical models. In this article, we report the evaluation of urinary biomarkers of ischemic tubular damage in a lamb preclinical LVAD model. We found that urinary excretion of glutathione-S-transferase-π, heat shock protein 1B, and hepatitis A virus cellular receptor 1 homologue precursor (HAVCR1/kidney injury molecule 1) were upregulated in toxic ischemic renal injury as well as in the immediate postoperative period in an LVAD-implanted lamb. These markers were consistent with both gross and histologic pathology, and proved far more sensitive for renal injury than serum blood urea nitrogen or creatinine concentrations.
Asunto(s)
Corazón Auxiliar/efectos adversos , Isquemia/orina , Enfermedades Renales/etiología , Enfermedades Renales/orina , Riñón/irrigación sanguínea , Riñón/patología , Animales , Gutatión-S-Transferasa pi/orina , Proteínas HSP70 de Choque Térmico/orina , Isquemia/etiología , Isquemia/patología , Enfermedades Renales/patología , Receptores Virales/metabolismo , Oveja DomésticaRESUMEN
BACKGROUND: Early urinary biomarkers may be useful in determining the severity of ischemic injury in donation after circulatory death (DCD) kidneys. The aim of this study was to evaluate the efficacy of a collective series of urinary biomarkers in relation to the warm and cold ischemic intervals. METHODS: Porcine kidneys were retrieved after 0, 10, and 25 min of warm ischemia (WI), then preserved by static cold storage (CS) for period of 2 and 18 h. After preservation, kidneys were reperfused on an isolated organ perfusion system to assess renal function and injury. Levels of IL-6, TNFα, endothelin-1 (ET-1), and neutrophil gelatinase-associated lipocalin (NGAL) were measured in urine samples after 3 h of reperfusion. RESULTS: There was no significant difference in renal functional parameters or urinary biomarkers between the WI times when kidneys were stored for 2 h (P > 0.05). After 18 h CS, kidneys with 10 and 25 min of WI demonstrated a significant decline in renal function compared with kidneys without WI (P < 0.05). Levels of ET-1 and NGAL were significantly higher in kidneys with 25 min WI (25 m ET-1, 30.1 ± 21.2, versus 0 m 2.25 ± 1.5 pg/mL; P = 0.002: NGAL, 25 m 77 ± 51 versus 0 m 10 ± 0.1 pg/mL; P = 0.005). Levels of IL-6 and TNFα were significantly higher in kidneys with 10 and 25 min of WI (P = 0.001, 0.001). CONCLUSION: Early urinary biomarkers are a useful means to determine graft injury. ET-1 and NGAL are more accurate in predicting the severity of ischemic injury compared with inflammatory markers.
Asunto(s)
Lesión Renal Aguda/orina , Biomarcadores/orina , Endotelina-1/orina , Isquemia/orina , Riñón/irrigación sanguínea , Lesión Renal Aguda/etiología , Animales , Isquemia Fría/efectos adversos , Interleucina-6/orina , Pruebas de Función Renal , Porcinos , Factor de Necrosis Tumoral alfa/orina , Isquemia Tibia/efectos adversosRESUMEN
PURPOSE: The aim of this prospective study was to investigate the effect of extracorporeal shock wave lithotripsy (SWL) on kidneys of patients with pyelic stone disease. The effects of SWL were assessed by high-resolution proton nuclear magnetic resonance (HNMR) spectroscopy of urine samples. METHODS: Twenty-three patients, aged 31-80years (mean: 55years), with pyelic stone disease were investigated before and after SWL. Multiparameter analysis was performed by HNMR spectroscopy of urine samples collected before and 5h after SWL (second miction post-SWL). RESULTS: The most relevant resonances determined by HNMR spectroscopy were acetate, lactate, trimethylamine N-oxide and amino acids. Excretion of these markers increased significantly in comparison with pre-SWL urinary samples. CONCLUSION: These results show that early ischemic damage occurs after SWL. Post-SWL. HNMR spectroscopy is an effective tool for noninvasive follow-up of renal damage.
Asunto(s)
Isquemia/diagnóstico , Isquemia/etiología , Riñón/irrigación sanguínea , Litotricia/efectos adversos , Espectroscopía de Resonancia Magnética , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Isquemia/orina , Cálculos Renales/terapia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , ProtonesRESUMEN
To determine urine cholinesterase activity in full-term neonatal infants with varying ischemic nephropathy in an intensive care unit, the investigators studied this enzyme on days 1 and 5-7 of life, by using a kinetic photometric test optimized according to the Deutsche Gesellschaft fur Klinische Chemie (German Society for Clinical Chemistry) recommendations. In the early neonatal period, the newborns with grade III ischemic nephropathy were found to have a high urine cholinesterase activity. The determination of urine cholinesterase activity just on the first day of life may be used for the early diagnosis of grade III ischemic nephropathy in the newborns until the clinical manifestations of this pathology develop.
Asunto(s)
Colinesterasas/orina , Enfermedades del Recién Nacido , Isquemia , Enfermedades Renales , Riñón/irrigación sanguínea , Femenino , Humanos , Recién Nacido , Enfermedades del Recién Nacido/diagnóstico , Enfermedades del Recién Nacido/enzimología , Enfermedades del Recién Nacido/orina , Isquemia/diagnóstico , Isquemia/enzimología , Isquemia/orina , Enfermedades Renales/diagnóstico , Enfermedades Renales/enzimología , Enfermedades Renales/orina , MasculinoRESUMEN
Platelets critically contribute to atherothrombosis and worsening ischaemia in patients with peripheral arterial disease (PAD), eventually leading to critical limb ischaemia (CLI). Furthermore, persistent platelet activation despite antiplatelet therapy has been reported in this setting. The prostacyclin analogue iloprost is currently recommended in CLI patients for its effects in relieving symptoms by promoting local perfusion. In this study, we investigated the effects of iloprost infusion on urinary 11-dehydro-TXB2 and 8-iso-PGF(2α) excretion rate, as in vivo indexes of thromboxane-dependent platelet activation and lipid peroxidation, respectively, and on platelet-derived proinflammatory sCD40L and nitric oxide bioavailability in 44 patients with CLI while on chronic treatment with low-dose aspirin. Daily iloprost infusion for one-week significantly decreased urinary 11-dehydro-TXB2 [499 (277-807) vs. 380 (189-560) pg/mg creatinine, p < 0.0001] and 8-iso-PGF(2α) [533 (316-842) vs. 334 (196-540) pg/mg creatinine, p < 0.0001] as well as plasma sCD40L [1540 (1005-3015) vs. 948 (845-2030) pg/ml, p < 0.0001]. Furthermore, a significant increase in plasma nitrate plus nitrite levels has been observed [26.8 (18.8-35.9) vs. 43.7 (33.0-75.5) µM, p < 0.0001]. A significant direct correlation was also found between urinary 8-iso-PGF(2α) and 11-dehydro-TXB2 before and after iloprost treatment (Rho = 0.695, p < 0.0001). In conclusion, we report that a short-term course of iloprost is able to significantly reduce residual thromboxane biosynthesis, oxidative stress, endothelial dysfunction and platelet-derived inflammation in low-dose aspirin treated patients with CLI.
Asunto(s)
Aspirina/uso terapéutico , Plaquetas/efectos de los fármacos , Iloprost/uso terapéutico , Mediadores de Inflamación/sangre , Isquemia/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Activación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Biomarcadores/orina , Plaquetas/inmunología , Ligando de CD40/sangre , Distribución de Chi-Cuadrado , Enfermedad Crítica , Dinoprost/análogos & derivados , Dinoprost/orina , Esquema de Medicación , Femenino , Humanos , Iloprost/administración & dosificación , Infusiones Intravenosas , Isquemia/sangre , Isquemia/inmunología , Isquemia/orina , Italia , Peroxidación de Lípido/efectos de los fármacos , Masculino , Persona de Mediana Edad , Óxido Nítrico/sangre , Inhibidores de Agregación Plaquetaria/administración & dosificación , Tromboxano B2/análogos & derivados , Tromboxano B2/orina , Factores de Tiempo , Resultado del TratamientoRESUMEN
The aim of this study was to evaluate urinary uric acid (UA) and lipid peroxidation levels, plasma myeloperoxidase (MPO) and adenosine deaminase (ADA) activities, and serum UA in neonatal rats subjected to hypoxia-ischemia neonatal HI model. The relevance of the findings is the fact that urinary lipid peroxidation and UA levels were significantly higher in 8 days in HI group when compared with the control, returning to baseline levels 60 days after HI. Hence, being an indication of purinic degradation during these first days post-HI. Furthermore, the higher levels of malondialdehyde (MDA) in urine in this period may be related to inadequate scavenging abilities of the immature nervous system and being noninvasive it may suggest the use of urinary MDA measurement as a marker for lipid peroxidation after HI insult. In application terms, these findings can help develop therapeutic interventions as soon as 8 days after HI.
Asunto(s)
Hipoxia , Isquemia , Peroxidación de Lípido/fisiología , Ácido Úrico/sangre , Ácido Úrico/orina , Albúminas/metabolismo , Animales , Animales Recién Nacidos , Modelos Animales de Enfermedad , Hipoxia/sangre , Hipoxia/fisiopatología , Hipoxia/orina , Isquemia/sangre , Isquemia/fisiopatología , Isquemia/orina , Masculino , Peroxidasa/orina , Ratas , Ratas Wistar , Estadísticas no Paramétricas , Factores de TiempoRESUMEN
Acute kidney injury (AKI) is a common disorder associated with high morbidity and mortality rates. Ischemia is the leading cause of AKI. This is a pilot study investigating the ability of multiple urinary cytokines to predict renal functional outcome and mortality in patients with ischemic AKI. Urine samples were obtained from 45 subjects with ischemic AKI on the day of renal consultation and 3 days later. The urinary concentrations of interleukin (IL)-1beta, IL-6, IL-8, monocyte chemotactic protein (MCP)-1, interferon-inducible protein (IP)-10, regulated on activation, normal T-expressed and secreted (RANTES), transforming growth factor (TGF)-alpha, vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF) were measured simultaneously using a microsphere-based immunofluorescence assay. Urinary cytokine levels (pg/mg urine creatinine), which predict renal functional recovery or no recovery the next day and 7 days and 3 months later, were identified. Increased urinary IP-10 and IL-8 predicted no renal functional recovery the next day. Increased urinary IP-10 and VEGF predicted no renal recovery by 7 days. Increased urinary IP-10 and VEGF predicted no renal recovery by 4 days, whereas increased urinary EGF predicted renal functional recovery at that time. Increased urinary IL-8, MCP-1, IP-10, RANTES, EGF, and VEGF predicted patient's death within 3 months. Our findings suggest that urinary IP-10, IL-8, VEGF, TGF-alpha, and EGF may predict renal functional outcome at various times along the course of ischemic AKI and that urinary IL-8, MCP-1, IP-10, RANTES, EGF, and VEGF may predict mortality of the patients within 3 months.
Asunto(s)
Lesión Renal Aguda/etiología , Lesión Renal Aguda/orina , Citocinas/orina , Isquemia/complicaciones , Isquemia/orina , Riñón/irrigación sanguínea , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Valor Predictivo de las Pruebas , Factores de TiempoRESUMEN
We aimed to determine whether remote ischemic preconditioning (IP) reduces renal damage following elective open infrarenal abdominal aortic aneurysm (AAA) repair. Sequential common iliac clamping was used to induce remote IP in randomized patients. Urinary retinol binding protein (RBP) and albumin-creatinine ratio (ACR) were measured following induction and 3, 24, and 48 hours postoperatively. In controls (n = 22), median urinary RBP increased from 112 microg/mL (interquartile range [IQR] 96-173 microg/mL) preoperatively to 5919 microg/mL (IQR 283-17 788 microg/mL) at 3 hours. Preoperative urinary RBP in preconditioned patients was 96 microg/mL (IQR 50 to 229 microg/mL) preoperatively, rising to 1243 microg/mL (IQR 540 to 15400 microg/mL) at 3 hours. Although control patients' median urinary RBP level was 5 times greater at 3 hours, there were no statistically significant differences in renal outcome indices. This trial could not confirm that remote IP reduces renal injury following elective open aneurysm surgery.
Asunto(s)
Aneurisma de la Aorta Abdominal/cirugía , Isquemia/prevención & control , Precondicionamiento Isquémico , Riñón/irrigación sanguínea , Procedimientos Quirúrgicos Vasculares , Anciano , Anciano de 80 o más Años , Albuminuria/etiología , Biomarcadores/orina , Constricción , Creatinina/orina , Procedimientos Quirúrgicos Electivos , Inglaterra , Femenino , Humanos , Arteria Ilíaca/cirugía , Isquemia/etiología , Isquemia/orina , Precondicionamiento Isquémico/métodos , Masculino , Persona de Mediana Edad , Proteínas de Unión al Retinol/orina , Factores de Tiempo , Resultado del Tratamiento , Procedimientos Quirúrgicos Vasculares/efectos adversosRESUMEN
To ascertain the level of medium-weight molecules in the plasma and urine in critically ill neonatal infants with varying ischemic nephropathy, the authors determined the content of medium-weight molecules by N. I. Gabrielyan's procedure modified by M. Ya. Malakhova. Within the first 24 hours of life, the newborn infants with ischemic nephropathy had high plasma levels of medium-weight proteins. The high plasma levels of medium-weight molecules were attended by their urinary elimination in first- and second-grade ischemic nephropathy and these were not compensated for by their elimination in third-grade nephropathy, which was linked to decreased renal excretory function. The determination of medium-weight molecules in the plasma and urine permits identification of acute renal failure in the newborn.